198 related articles for article (PubMed ID: 36687675)
1. The temporal trend of disease burden attributable to metabolic risk factors in China, 1990-2019: An analysis of the Global Burden of Disease study.
Jin Y; So H; Cerin E; Barnett A; Mubarik S; Hezam K; Feng X; Wang Z; Huang J; Zhong C; Hayat K; Wang F; Wu AM; Xu S; Zou Z; Lim LL; Cai J; Song Y; Tam LS; Wu D
Front Nutr; 2022; 9():1035439. PubMed ID: 36687675
[TBL] [Abstract][Full Text] [Related]
2. Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017.
Wu D; Wong P; Guo C; Tam LS; Gu J
BMC Med; 2021 Feb; 19(1):34. PubMed ID: 33536019
[TBL] [Abstract][Full Text] [Related]
3. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis.
Wang C; Yang X; Zhang H; Zhang Y; Tao J; Jiang X; Wu C
Front Public Health; 2023; 11():1225931. PubMed ID: 37575123
[TBL] [Abstract][Full Text] [Related]
5. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
[TBL] [Abstract][Full Text] [Related]
6. Burden of falls attributable to low bone mineral density among people aged 60 years and over in China from 1990 to 2019.
Fu Y; Ba L; Lü N; Yang H; Hong X; Zhou J; Sun Z
Front Public Health; 2023; 11():1204497. PubMed ID: 37448662
[TBL] [Abstract][Full Text] [Related]
7. The burden of cardiovascular disease attributable to high body mass index-an observational study.
Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y; Wang JG
Eur Heart J Qual Care Clin Outcomes; 2024 Mar; 10(2):154-167. PubMed ID: 37481694
[TBL] [Abstract][Full Text] [Related]
8. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
[TBL] [Abstract][Full Text] [Related]
9. Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.
Wang M; Liu J; Yan L; Wang J; Jin Y; Zheng ZJ
J Nutr Health Aging; 2024 Jun; 28(6):100261. PubMed ID: 38810511
[TBL] [Abstract][Full Text] [Related]
10. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.
Yang G; Wang Y; Zeng Y; Gao GF; Liang X; Zhou M; Wan X; Yu S; Jiang Y; Naghavi M; Vos T; Wang H; Lopez AD; Murray CJ
Lancet; 2013 Jun; 381(9882):1987-2015. PubMed ID: 23746901
[TBL] [Abstract][Full Text] [Related]
11. The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019.
Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y
Diabetes Metab Syndr; 2024 May; 18(5):103025. PubMed ID: 38851022
[TBL] [Abstract][Full Text] [Related]
12. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
[TBL] [Abstract][Full Text] [Related]
13. Burden and trends of stroke attributable to dietary risk factors from 1990 to 2019 in the Belt and Road Initiative countries: an analysis from the global burden of disease study 2019.
Zhang Y; Luo Z; Yi J; Zhu J; Qiu Y; Xu X; Xie W; Wu J; Lv H; Mou C; Zhang W; Li X
Front Nutr; 2023; 10():1235271. PubMed ID: 37565042
[TBL] [Abstract][Full Text] [Related]
14. Trends in deaths and disability-adjusted life-years of stroke attributable to high body-mass index worldwide, 1990-2019.
Guo X; Li J; Yin X; Zhang Z; Zhong Q; Zhu F
Front Neurol; 2023; 14():1211642. PubMed ID: 37456638
[TBL] [Abstract][Full Text] [Related]
15. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
[TBL] [Abstract][Full Text] [Related]
16. Spatial and Temporal Patterns of Disease Burden attributable to High Body Mass Index in Belt and Road Initiative Countries, 1990-2019.
Xu Y; Wang Q; Yu T; Han Y; Dai W; Jiang S; Li X
Public Health Nutr; 2024 Jun; ():1-31. PubMed ID: 38835207
[TBL] [Abstract][Full Text] [Related]
17. The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019.
Shen Y; Huang X; Wu J; Lin X; Zhou X; Zhu Z; Pan X; Xu J; Qiao J; Zhang T; Ye L; Jiang H; Ren Y; Shan PF
Front Endocrinol (Lausanne); 2022; 13():882241. PubMed ID: 35669691
[TBL] [Abstract][Full Text] [Related]
18. Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019 study.
Lin XL; Zhang QW; Chen GF; Yang SJ; Li XB; Deng WY
Metabolism; 2024 Jun; 157():155954. PubMed ID: 38878856
[TBL] [Abstract][Full Text] [Related]
19. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.
Nascimento BR; Brant LCC; Yadgir S; Oliveira GMM; Roth G; Glenn SD; Mooney M; Naghavi M; Passos VMA; Duncan BB; Silva DAS; Malta DC; Ribeiro ALP
Popul Health Metr; 2020 Sep; 18(Suppl 1):17. PubMed ID: 32993676
[TBL] [Abstract][Full Text] [Related]
20. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
